USA Molecular Diagnosis (MDx) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Molecular Diagnosis (MDx) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Molecular Diagnosis (MDx) market. Detailed analysis of key players, along with key growth strategies adopted by Molecular Diagnosis (MDx) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Hologic

    • Qiagen

    • Roche Diagnostics

    • BD

    • Biomerieux

    • Agilent Technologies

    By Type:

    • Noninvasive Prenatal Testing (NIPT)

    • Along With The Diagnosis

    • Liquid Biopsy

    • Other Molecular Diagnostics

    By End-User:

    • Cardiovascular

    • Neurology

    • Gastroenterology

    • Infectious Diseases

    • Oncology

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Molecular Diagnosis (MDx) Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Noninvasive Prenatal Testing (NIPT) from 2016 to 2027

      • 1.3.2 USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Along With The Diagnosis from 2016 to 2027

      • 1.3.3 USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Liquid Biopsy from 2016 to 2027

      • 1.3.4 USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Other Molecular Diagnostics from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Cardiovascular from 2016 to 2027

      • 1.4.2 USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Neurology from 2016 to 2027

      • 1.4.3 USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Gastroenterology from 2016 to 2027

      • 1.4.4 USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Infectious Diseases from 2016 to 2027

      • 1.4.5 USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Oncology from 2016 to 2027

      • 1.4.6 USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Molecular Diagnosis (MDx) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Molecular Diagnosis (MDx) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Molecular Diagnosis (MDx) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Molecular Diagnosis (MDx) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Molecular Diagnosis (MDx) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Molecular Diagnosis (MDx) by Major Types

      • 3.4.1 Market Size and Growth Rate of Noninvasive Prenatal Testing (NIPT)

      • 3.4.2 Market Size and Growth Rate of Along With The Diagnosis

      • 3.4.3 Market Size and Growth Rate of Liquid Biopsy

      • 3.4.4 Market Size and Growth Rate of Other Molecular Diagnostics

    4 Segmentation of Molecular Diagnosis (MDx) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Molecular Diagnosis (MDx) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Molecular Diagnosis (MDx) in Cardiovascular

      • 4.4.2 Market Size and Growth Rate of Molecular Diagnosis (MDx) in Neurology

      • 4.4.3 Market Size and Growth Rate of Molecular Diagnosis (MDx) in Gastroenterology

      • 4.4.4 Market Size and Growth Rate of Molecular Diagnosis (MDx) in Infectious Diseases

      • 4.4.5 Market Size and Growth Rate of Molecular Diagnosis (MDx) in Oncology

      • 4.4.6 Market Size and Growth Rate of Molecular Diagnosis (MDx) in Other

    5 Market Analysis by Regions

    • 5.1 USA Molecular Diagnosis (MDx) Production Analysis by Regions

    • 5.2 USA Molecular Diagnosis (MDx) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Molecular Diagnosis (MDx) Landscape Analysis

    • 6.1 West USA Molecular Diagnosis (MDx) Landscape Analysis by Major Types

    • 6.2 West USA Molecular Diagnosis (MDx) Landscape Analysis by Major End-Users

    7 South USA Molecular Diagnosis (MDx) Landscape Analysis

    • 7.1 South USA Molecular Diagnosis (MDx) Landscape Analysis by Major Types

    • 7.2 South USA Molecular Diagnosis (MDx) Landscape Analysis by Major End-Users

    8 Middle West USA Molecular Diagnosis (MDx) Landscape Analysis

    • 8.1 Middle West USA Molecular Diagnosis (MDx) Landscape Analysis by Major Types

    • 8.2 Middle West USA Molecular Diagnosis (MDx) Landscape Analysis by Major End-Users

    9 Northeast USA Molecular Diagnosis (MDx) Landscape Analysis

    • 9.1 Northeast USA Molecular Diagnosis (MDx) Landscape Analysis by Major Types

    • 9.2 Northeast USA Molecular Diagnosis (MDx) Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Hologic

        • 10.1.1 Hologic Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Qiagen

        • 10.2.1 Qiagen Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Roche Diagnostics

        • 10.3.1 Roche Diagnostics Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 BD

        • 10.4.1 BD Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Biomerieux

        • 10.5.1 Biomerieux Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Agilent Technologies

        • 10.6.1 Agilent Technologies Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Noninvasive Prenatal Testing (NIPT) from 2016 to 2027

    • Figure USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Along With The Diagnosis from 2016 to 2027

    • Figure USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Liquid Biopsy from 2016 to 2027

    • Figure USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Other Molecular Diagnostics from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Cardiovascular from 2016 to 2027

    • Figure USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Neurology from 2016 to 2027

    • Figure USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Gastroenterology from 2016 to 2027

    • Figure USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Infectious Diseases from 2016 to 2027

    • Figure USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Oncology from 2016 to 2027

    • Figure USA Molecular Diagnosis (MDx) Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Molecular Diagnosis (MDx) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Molecular Diagnosis (MDx) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Molecular Diagnosis (MDx) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Molecular Diagnosis (MDx) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Molecular Diagnosis (MDx) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Molecular Diagnosis (MDx)

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Molecular Diagnosis (MDx) by Different Types from 2016 to 2027

    • Table Consumption Share of Molecular Diagnosis (MDx) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Noninvasive Prenatal Testing (NIPT)

    • Figure Market Size and Growth Rate of Along With The Diagnosis

    • Figure Market Size and Growth Rate of Liquid Biopsy

    • Figure Market Size and Growth Rate of Other Molecular Diagnostics

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Molecular Diagnosis (MDx) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Molecular Diagnosis (MDx) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Cardiovascular

    • Figure Market Size and Growth Rate of Neurology

    • Figure Market Size and Growth Rate of Gastroenterology

    • Figure Market Size and Growth Rate of Infectious Diseases

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Other

    • Table USA Molecular Diagnosis (MDx) Production by Regions

    • Table USA Molecular Diagnosis (MDx) Production Share by Regions

    • Figure USA Molecular Diagnosis (MDx) Production Share by Regions in 2016

    • Figure USA Molecular Diagnosis (MDx) Production Share by Regions in 2021

    • Figure USA Molecular Diagnosis (MDx) Production Share by Regions in 2027

    • Table USA Molecular Diagnosis (MDx) Consumption by Regions

    • Table USA Molecular Diagnosis (MDx) Consumption Share by Regions

    • Figure USA Molecular Diagnosis (MDx) Consumption Share by Regions in 2016

    • Figure USA Molecular Diagnosis (MDx) Consumption Share by Regions in 2021

    • Figure USA Molecular Diagnosis (MDx) Consumption Share by Regions in 2027

    • Table West USA Molecular Diagnosis (MDx) Consumption by Types from 2016 to 2027

    • Table West USA Molecular Diagnosis (MDx) Consumption Share by Types from 2016 to 2027

    • Figure West USA Molecular Diagnosis (MDx) Consumption Share by Types in 2016

    • Figure West USA Molecular Diagnosis (MDx) Consumption Share by Types in 2021

    • Figure West USA Molecular Diagnosis (MDx) Consumption Share by Types in 2027

    • Table West USA Molecular Diagnosis (MDx) Consumption by End-Users from 2016 to 2027

    • Table West USA Molecular Diagnosis (MDx) Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Molecular Diagnosis (MDx) Consumption Share by End-Users in 2016

    • Figure West USA Molecular Diagnosis (MDx) Consumption Share by End-Users in 2021

    • Figure West USA Molecular Diagnosis (MDx) Consumption Share by End-Users in 2027

    • Table South USA Molecular Diagnosis (MDx) Consumption by Types from 2016 to 2027

    • Table South USA Molecular Diagnosis (MDx) Consumption Share by Types from 2016 to 2027

    • Figure South USA Molecular Diagnosis (MDx) Consumption Share by Types in 2016

    • Figure South USA Molecular Diagnosis (MDx) Consumption Share by Types in 2021

    • Figure South USA Molecular Diagnosis (MDx) Consumption Share by Types in 2027

    • Table South USA Molecular Diagnosis (MDx) Consumption by End-Users from 2016 to 2027

    • Table South USA Molecular Diagnosis (MDx) Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Molecular Diagnosis (MDx) Consumption Share by End-Users in 2016

    • Figure South USA Molecular Diagnosis (MDx) Consumption Share by End-Users in 2021

    • Figure South USA Molecular Diagnosis (MDx) Consumption Share by End-Users in 2027

    • Table Middle West USA Molecular Diagnosis (MDx) Consumption by Types from 2016 to 2027

    • Table Middle West USA Molecular Diagnosis (MDx) Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Molecular Diagnosis (MDx) Consumption Share by Types in 2016

    • Figure Middle West USA Molecular Diagnosis (MDx) Consumption Share by Types in 2021

    • Figure Middle West USA Molecular Diagnosis (MDx) Consumption Share by Types in 2027

    • Table Middle West USA Molecular Diagnosis (MDx) Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Molecular Diagnosis (MDx) Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Molecular Diagnosis (MDx) Consumption Share by End-Users in 2016

    • Figure Middle West USA Molecular Diagnosis (MDx) Consumption Share by End-Users in 2021

    • Figure Middle West USA Molecular Diagnosis (MDx) Consumption Share by End-Users in 2027

    • Table Northeast USA Molecular Diagnosis (MDx) Consumption by Types from 2016 to 2027

    • Table Northeast USA Molecular Diagnosis (MDx) Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Molecular Diagnosis (MDx) Consumption Share by Types in 2016

    • Figure Northeast USA Molecular Diagnosis (MDx) Consumption Share by Types in 2021

    • Figure Northeast USA Molecular Diagnosis (MDx) Consumption Share by Types in 2027

    • Table Northeast USA Molecular Diagnosis (MDx) Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Molecular Diagnosis (MDx) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Molecular Diagnosis (MDx) Consumption Share by End-Users in 2016

    • Figure Northeast USA Molecular Diagnosis (MDx) Consumption Share by End-Users in 2021

    • Figure Northeast USA Molecular Diagnosis (MDx) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Hologic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hologic

    • Figure Sales and Growth Rate Analysis of Hologic

    • Figure Revenue and Market Share Analysis of Hologic

    • Table Product and Service Introduction of Hologic

    • Table Company Profile and Development Status of Qiagen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen

    • Figure Sales and Growth Rate Analysis of Qiagen

    • Figure Revenue and Market Share Analysis of Qiagen

    • Table Product and Service Introduction of Qiagen

    • Table Company Profile and Development Status of Roche Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Diagnostics

    • Figure Sales and Growth Rate Analysis of Roche Diagnostics

    • Figure Revenue and Market Share Analysis of Roche Diagnostics

    • Table Product and Service Introduction of Roche Diagnostics

    • Table Company Profile and Development Status of BD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BD

    • Figure Sales and Growth Rate Analysis of BD

    • Figure Revenue and Market Share Analysis of BD

    • Table Product and Service Introduction of BD

    • Table Company Profile and Development Status of Biomerieux

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biomerieux

    • Figure Sales and Growth Rate Analysis of Biomerieux

    • Figure Revenue and Market Share Analysis of Biomerieux

    • Table Product and Service Introduction of Biomerieux

    • Table Company Profile and Development Status of Agilent Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent Technologies

    • Figure Sales and Growth Rate Analysis of Agilent Technologies

    • Figure Revenue and Market Share Analysis of Agilent Technologies

    • Table Product and Service Introduction of Agilent Technologies


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.